Croda: Life Sciences Specialty Chemicals
Former Senior Executive at Croda
inpractise.com/articles/croda-life-sciences-specialty-chemicals
Croda: Life Sciences Specialty Chemicals(September 16, 2024)
Former Senior Executive at Croda
Interview Transcript
This is a snippet of the transcript, sign up to read more.
Why do you need the commodity business? Could you not have smaller plants or fewer plants and just focus on the really high-end products?
If you are a sales rep for Croda, you have your targets. You don't want to sell commodities; there is no target for commodities at all. However, it's good to have them because you can offer a full package to the customer. You can sell the active ingredient, the specialty, the fancy stuff that allows for great claims, and the fillers needed for formulation. If I can sell the whole package, it's a win-win.
This is a snippet of the transcript, sign up to read more.
Why do you need the commodity business? Could you not have smaller plants or fewer plants and just focus on the really high-end products?
It's essential to use the commodity business to approach these customers and gain volume. Once you have a foot in the door, you can then sell the specialty products, which are what make you money due to their high margins. It's a combination. The focus is on the specialties, but sometimes for new technologies and innovations, it's difficult to open doors because it's a bit riskier and different.
This is a snippet of the transcript, sign up to read more.
Related Content
IMCD: Principal - Distributor Dynamics
Former Managing Director at IMCD
IMCD Group: APAC Region, M&A Strategy & Management Changes
Former Vice President at IMCD Group
IMCD: Customer Value-Add
Former International Sales Manager at IMCD
TransDigm: Boeing vs OEM Supplier Bargaining Power, Vitec, Atlassian, Mister Car Wash, Nubank ,Wayfair
Copyright Notice
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.